Farewell VitalMedix
Posted on July 10th, 2009 – 11:22 AMBy Thomas Lee
It’s official. VitalMedix Inc., the promising University of Minnesota drug startup, is leaving for Wisconsin.
The company, which is developing a hemorrhagic shock drug designed to keep patients alive even after catastrophic blood loss, hasn’t been able to find investors in Minnesota. Wisconsin, on the other hand, boasts a thriving angel investor community thanks to generous investment tax credits (see previous “Wisconsin kicks our butt” post further down the page).
“This company has got to survive,” VitalMedix CEO Jeff Williams said. “This technology is too important.”
Williams said the company has not yet signed a lease but will do so by the end of the year.
2 Responses to "Farewell VitalMedix"
This technology sounds incredible!!
I had an ectopic pregnancy in 1995 and was only seconds away of going into shock from blood loss. I live in Hudson
and am very happy your company is moving to Wisconsin. I am an individual
not a corporation but if you could use an employee to help out with clinical trials, or any openings the company may have I would love to apply. Is it possible to get more info on this medication? I am very interested.
THANK YOU.
Mitzi McRoberts
The state of MN isn’t the problem. VitalMedix today just isn’t a bankable organization for a number of reasons including the leadership team and market size.
